Latest Reimbursement News

Lumos Diagnostics reported a robust Q2 FY25 with a 71% revenue increase to US$2.9 million, driven by strong product and service sales, alongside a strategic US$3 million BARDA partnership to advance its FebriDx test.

Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.

Magnum Mining and Exploration Limited moves forward with acquiring two promising rare earth element projects in Brazil while progressing negotiations on a green pig iron venture in Saudi Arabia.

Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.

American Rare Earths advances its Halleck Creek Project with record high-grade drilling results, a strategic collaboration with BMO Capital Markets, and a significant state grant, reinforcing its role in securing the U.S. rare earth supply chain.

Great Boulder Resources has reported robust exploration results at its Side Well Gold Project, uncovering significant high-grade gold mineralisation and confirming excellent metallurgical recoveries. The company is advancing towards resource growth and mining approvals while progressing the divestment of its Whiteheads project.

Charger Metals NL reports significant progress in its lithium exploration projects at Lake Johnston and Bynoe, backed by Rio Tinto's funding and a recent $0.77 million capital raise. Upcoming assay results and drilling programs could shape the company’s growth trajectory.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.